Astrazeneca reported 10.23B in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
AstraZeneca AZN:LN 840.42B 39.99B
Astrazeneca AZN:US 10.23B 280M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Canopy Growth Corp WEED:CN C$ 1.95B 1.3B
Catalent CTLT:US $ 1.07B 5M
Corcept Therapeutics CORT:US $ 71.95M 5.04M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Genmab GEN:DC 1.92B 310M
GlaxoSmithKline GSK:LN 584.8B 95.1B
Horizon Pharma HZNP:US $ 787.85M 96.93M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Johnson & Johnson JNJ:US $ 18.18B 616M
Lannett LCI:US $ 152.15M 51.71M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Pfizer PFE:US $ 15640M 148M
Prestige Brands PBH:US $ 190.04M 534K
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
Valeant Pharmaceuticals VRX:CN C$ 2.18B 546.23M
Zoetis ZTS:US $ 1.38B 123M